{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T07:24:57Z","timestamp":1787210697896,"version":"build-2736575974"},"reference-count":225,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":120,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04459-2","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T23:32:46Z","timestamp":1776814366000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Silicon quantum dots for neurotheranostic applications in dopamine detection"],"prefix":"10.1186","volume":"24","author":[{"given":"Shi","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuewen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haishan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shasha","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"4459_CR1","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3390\/brainsci13020272","volume":"13","author":"S Sandeep","year":"2023","unstructured":"Sandeep S, et al. Could Vitamins Have a Positive Impact on the Treatment of Parkinson\u2019s Disease? Brain Sci. 2023;13:272.","journal-title":"Brain Sci"},{"key":"4459_CR2","doi-asserted-by":"crossref","unstructured":"Zhou ZD et al. Role of dopamine in the pathophysiology of Parkinson\u2019s disease. Transl Neurodegener, 2023;44;12.","DOI":"10.1186\/s40035-023-00378-6"},{"key":"4459_CR3","doi-asserted-by":"publisher","first-page":"9435","DOI":"10.1073\/pnas.0400569101","volume":"101","author":"EJ Benner","year":"2004","unstructured":"Benner EJ, et al. Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson\u2019s disease. Proc Natl Acad Sci U S A. 2004;101:9435\u201340.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4459_CR4","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13031","author":"BG Trist","year":"2019","unstructured":"Trist BG, Hare DJ, Double KL. Oxidative stress in the aging substantia nigra and the etiology of Parkinson\u2019s disease. Aging Cell. 2019. https:\/\/doi.org\/10.1111\/acel.13031.","journal-title":"Aging Cell"},{"key":"4459_CR5","doi-asserted-by":"crossref","unstructured":"Lima MMS et al. A Review of Clinical and Experimental Studies, CNS & Neurological Disorders \u2013 Drug Targets (CNSNDDT), 2012. 11: pp. 439\u201349.","DOI":"10.2174\/187152712800792893"},{"key":"4459_CR6","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1111\/j.1460-9568.2012.08162.x","volume":"35","author":"HS Lindgren","year":"2012","unstructured":"Lindgren HS. Dunnett, cognitive dysfunction and depression in Parkinson\u2019s disease: what can be learned from rodent models? Eur J Neurosci. 2012;35:1894\u2013907.","journal-title":"Eur J Neurosci"},{"key":"4459_CR7","doi-asserted-by":"crossref","unstructured":"Yal\u00e7in M et al. Circadian clock dysfunction in Parkinson\u2019s disease: mechanisms, consequences, and therapeutic strategy, Npj Parkinsons Dis. 2025. 11.","DOI":"10.1038\/s41531-025-01009-9"},{"key":"4459_CR8","doi-asserted-by":"crossref","unstructured":"Magrinelli F et al. Pathophysiology of Motor Dysfunction in Parkinson\u2019s Disease as the Rationale for Drug Treatment and Rehabilitation., Parkinson\u2019s Disease 2016. 2016: pp. 1\u201318.","DOI":"10.1155\/2016\/9832839"},{"key":"4459_CR9","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3233\/JAD-2010-091459","volume":"20","author":"RDS Prediger","year":"2010","unstructured":"Prediger RDS. Effects of caffeine in Parkinson\u2019s disease: from neuroprotection to the management of motor and non-motor symptoms. JAD. 2010;20:205\u201320.","journal-title":"JAD"},{"key":"4459_CR10","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1007\/s12272-021-01337-3","volume":"44","author":"Y Bang","year":"2021","unstructured":"Bang Y, Lim J, Choi HJ. Recent advances in the pathology of prodromal non-motor symptoms olfactory deficit and depression in Parkinson\u2019s disease: clues to early diagnosis and effective treatment. Arch Pharm Res. 2021;44:588\u2013604.","journal-title":"Arch. Pharm. Res"},{"key":"4459_CR11","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1007\/s11064-023-03960-6","volume":"5","author":"T Siddiqui","year":"2023","unstructured":"Siddiqui T, Bhatt LK. Targeting sigma-1 receptor: a promising strategy in the treatment of Parkinson\u2019s disease. Neurochem Res. 2023;5:2925\u201335.","journal-title":"Neurochem Res"},{"key":"4459_CR12","doi-asserted-by":"crossref","unstructured":"Liu Z, Cheung HH. Stem Cell-Based Ther Parkinson Disease IJMS 2020:14; p. 21.","DOI":"10.3390\/ijms21218060"},{"key":"4459_CR13","doi-asserted-by":"publisher","first-page":"100994","DOI":"10.1016\/j.arr.2019.100994","volume":"57","author":"P Yang","year":"2019","unstructured":"Yang P, et al. Dopamine D3 receptor: A neglected participant in Parkinson Disease pathogenesis and treatment? Ageing Res Rev. 2019;57:100994.","journal-title":"Ageing Res Rev"},{"issue":"1","key":"4459_CR14","doi-asserted-by":"publisher","first-page":"4364","DOI":"10.1038\/s41467-020-18128-x","volume":"11","author":"T Yamaguchi","year":"2020","unstructured":"Yamaguchi T, et al. Cardiac dopamine D1 receptor triggers ventricular arrhythmia in chronic heart failure. Nat Commun. 2020;11(1):4364.","journal-title":"Nat Commun"},{"issue":"1","key":"4459_CR15","doi-asserted-by":"publisher","first-page":"16861","DOI":"10.1038\/s41598-019-52528-4","volume":"9","author":"F Han","year":"2019","unstructured":"Han F, et al. Dopamine D(2) receptor modulates Wnt expression and control of cell proliferation. Sci Rep. 2019;9(1):16861.","journal-title":"Sci Rep"},{"issue":"9","key":"4459_CR16","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1056\/NEJMoa0907118","volume":"362","author":"D De Backer","year":"2010","unstructured":"De Backer D, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010;362(9):779\u201389.","journal-title":"N Engl J Med"},{"issue":"3","key":"4459_CR17","doi-asserted-by":"publisher","first-page":"211","DOI":"10.2174\/0118715249302594240801171612","volume":"25","author":"M Nikbakhtzadeh","year":"2025","unstructured":"Nikbakhtzadeh M, et al. Significance of Neurotransmitters in Cerebral Ischemia: Understanding the Role of Serotonin, Dopamine, Glutamate, and GABA in Stroke Recovery and Treatment. Cent Nerv Syst Agents Med Chem. 2025;25(3):211\u201329.","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"4459_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10121917","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, et al. ROS-induced mtDNA release: the emerging messenger for communication between neurons and innate immune cells during neurodegenerative disorder progression. Antioxidants. 2021. https:\/\/doi.org\/10.3390\/antiox10121917.","journal-title":"Antioxidants"},{"key":"4459_CR19","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1093\/brain\/awae177","volume":"147","author":"C Roodveldt","year":"2024","unstructured":"Roodveldt C, et al. The immune system in Parkinson\u2019s disease: what we know so far. Brain. 2024;147:3306\u201324.","journal-title":"Brain"},{"key":"4459_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2020.572090","author":"K Mayne","year":"2020","unstructured":"Mayne K, et al. Aging and neurodegenerative disease: is the adaptive immune system a friend or foe? Front Aging Neurosci. 2020. https:\/\/doi.org\/10.3389\/fnagi.2020.572090.","journal-title":"Front Aging Neurosci"},{"key":"4459_CR21","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s12272-019-01133-0","volume":"42","author":"Y Lee","year":"2019","unstructured":"Lee Y, et al. Significant roles of neuroinflammation in Parkinson\u2019s disease: therapeutic targets for PD prevention. Arch Pharm Res. 2019;42:416\u201325.","journal-title":"Arch Pharm Res"},{"key":"4459_CR22","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1111\/cns.13429","volume":"26","author":"M Ugrumov","year":"2020","unstructured":"Ugrumov M. Development of early diagnosis of Parkinson\u2019s disease: illusion or reality? CNS Neurosci Ther. 2020;26:997\u20131009.","journal-title":"CNS Neurosci Ther"},{"issue":"3","key":"4459_CR23","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s10143-018-1047-9","volume":"43","author":"AT Hale","year":"2020","unstructured":"Hale AT, et al. Deep brain stimulation in pediatric dystonia: a systematic review. Neurosurg Rev. 2020;43(3):873\u201380.","journal-title":"Neurosurg Rev"},{"issue":"10423","key":"4459_CR24","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","volume":"403","author":"Y Ben-Shlomo","year":"2024","unstructured":"Ben-Shlomo Y, et al. The epidemiology of Parkinson\u2019s disease. Lancet. 2024;403(10423):283\u201392.","journal-title":"Lancet"},{"key":"4459_CR25","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1002\/ana.26187","volume":"90","author":"A Verger","year":"2021","unstructured":"Verger A, et al. Single Photon Emission Computed Tomography\/Positron Emission Tomography Molecular Imaging for Parkinsonism: A Fast-Developing Field. Ann Neurol. 2021;90:711\u20139.","journal-title":"Ann Neurol"},{"key":"4459_CR26","first-page":"433","volume":"5","author":"FM Lu","year":"2015","unstructured":"Lu FM, Yuan Z. PET\/SPECT molecular imaging in clinical neuroscience: recent advances in the investigation of CNS diseases. Quant Imaging Med Surg. 2015;5:433\u201347.","journal-title":"Quant Imaging Med Surg"},{"key":"4459_CR27","doi-asserted-by":"publisher","first-page":"572","DOI":"10.2174\/1871527319666200722153156","volume":"19","author":"H Bogetofte","year":"2020","unstructured":"Bogetofte H, et al. Levodopa Therapy for Parkinson\u2019s Disease: History, Current Status and Perspectives. CNSNDDT. 2020;19:572\u201383.","journal-title":"CNSNDDT"},{"key":"4459_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2202-9-S3-S5","author":"LR Hanson","year":"2008","unstructured":"Hanson LR, Frey WH. Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease. BMC Neurosci. 2008. https:\/\/doi.org\/10.1186\/1471-2202-9-S3-S5.","journal-title":"BMC Neurosci"},{"key":"4459_CR29","doi-asserted-by":"crossref","unstructured":"Anwarkhan S, Koilpillai J, Narayanasamy D. Utilizing Multifaceted Approaches to Target Drug Delivery in the Brain: From Nanoparticles to Biological Therapies. Cureus, 2024;9;16.","DOI":"10.7759\/cureus.68419"},{"key":"4459_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/mds.20458","volume":"20","author":"J Jankovic","year":"2005","unstructured":"Jankovic J. Motor fluctuations and dyskinesias in Parkinson\u2019s disease: clinical manifestations. Mov Disord. 2005;20:11\u20136.","journal-title":"Mov Disord"},{"key":"4459_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.989471","author":"MM Rhaman","year":"2022","unstructured":"Rhaman MM, et al. Exploring the role of nanomedicines for the therapeutic approach of central nervous system dysfunction: at a glance. Front Cell Dev Biol. 2022. https:\/\/doi.org\/10.3389\/fcell.2022.989471.","journal-title":"Front Cell Dev Biol"},{"key":"4459_CR32","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.2217\/nnm-2021-0104","volume":"16","author":"MD Villalva","year":"2021","unstructured":"Villalva MD, et al. Quantum dots as a theranostic approach in Alzheimer\u2019s disease: a systematic review. Nanomed (Lond. 2021;16:1595\u2013611.","journal-title":"Nanomed (Lond"},{"key":"4459_CR33","doi-asserted-by":"publisher","first-page":"1535682","DOI":"10.3389\/fmed.2025.1535682","volume":"12","author":"VK Yadav","year":"2025","unstructured":"Yadav VK, et al. Recent advances in nanotechnology for Parkinson\u2019s disease: diagnosis, treatment, and future perspectives. Front Med. 2025;12:1535682.","journal-title":"Front Med"},{"key":"4459_CR34","doi-asserted-by":"publisher","first-page":"100072","DOI":"10.1016\/j.bea.2023.100072","volume":"5","author":"BD Latha","year":"2023","unstructured":"Latha BD, et al. Fluorescent carbon quantum dots for effective tumor diagnosis: A comprehensive review. Biomedical Eng Adv. 2023;5:100072.","journal-title":"Biomedical Eng Adv"},{"key":"4459_CR35","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1021\/nl025538c","volume":"2","author":"DS English","year":"2002","unstructured":"English DS, et al. Size Tunable Visible Luminescence from Individual Organic Monolayer Stabilized Silicon Nanocrystal Quantum Dots. Nano Lett. 2002;2:681\u20135.","journal-title":"Nano Lett"},{"key":"4459_CR36","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.1039\/b926512k","volume":"39","author":"V Biju","year":"2010","unstructured":"Biju V, Itoh T, Ishikawa M. Delivering quantum dots to cells: bioconjugated quantum dots for targeted and nonspecific extracellular and intracellular imaging. Chem Soc Rev. 2010;39:3031.","journal-title":"Chem Soc Rev"},{"key":"4459_CR37","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1002\/smll.201402648","volume":"11","author":"XT Zheng","year":"2014","unstructured":"Zheng XT, et al. Glowing graphene quantum dots and carbon dots: properties, syntheses, and biological applications. Small. 2014;11:1620\u201336.","journal-title":"Small"},{"key":"4459_CR38","doi-asserted-by":"crossref","unstructured":"Pechnikova NA et al. Carbon Quantum Dots in Biomedical Applications: Advances, Challenges, and Future Prospects, Aggregate 6. 2024.","DOI":"10.1002\/agt2.707"},{"key":"4459_CR39","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1021\/acs.jpclett.6b01164","volume":"7","author":"S Dey","year":"2016","unstructured":"Dey S, et al. <article-title update=\"added\">Plasmonic effect on exciton and multiexciton emission of single quantum dots. J Phys Chem Lett. 2016;7:2921\u20139.","journal-title":"J Phys Chem Lett"},{"key":"4459_CR40","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.2147\/NDT.S540718","volume":"21","author":"H Bai","year":"2025","unstructured":"Bai H, et al. Updates on Parkinson\u2019s Disease. NDT. 2025;21:1945\u201353.","journal-title":"NDT"},{"key":"4459_CR41","doi-asserted-by":"crossref","unstructured":"Perini G et al. Unravelling the Potential of Graphene Quantum Dots in Biomedicine and Neuroscience. IJMS, 2020: p. 21.","DOI":"10.3390\/ijms21103712"},{"key":"4459_CR42","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1002\/mds.27722","volume":"34","author":"PA Lewitt","year":"2019","unstructured":"Lewitt PA, Lipsman N, Kordower JH. Focused ultrasound opening of the blood-brain barrier for treatment of Parkinson\u2019s disease. Mov Disord. 2019;34:1274\u20138.","journal-title":"Mov Disord"},{"key":"4459_CR43","doi-asserted-by":"publisher","first-page":"2201655","DOI":"10.1002\/adhm.202201655","volume":"11","author":"Y Gao","year":"2022","unstructured":"Gao Y, et al. NIR-Assisted MgO-Based Polydopamine Nanoparticles for Targeted Treatment of Parkinson\u2019s Disease through the Blood-Brain Barrier. Adv Healthc Mater. 2022;11:2201655.","journal-title":"Adv Healthc Mater"},{"key":"4459_CR44","doi-asserted-by":"publisher","first-page":"5131","DOI":"10.1021\/nn101016f","volume":"4","author":"F Erogbogbo","year":"2010","unstructured":"Erogbogbo F, et al. Biocompatible Magnetofluorescent Probes: Luminescent Silicon Quantum Dots Coupled with Superparamagnetic Iron(III) Oxide. ACS Nano. 2010;4:5131\u20138.","journal-title":"ACS Nano"},{"key":"4459_CR45","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1021\/nl504051x","volume":"15","author":"T Zhou","year":"2015","unstructured":"Zhou T, et al. Bandgap Tuning of Silicon Quantum Dots by Surface Functionalization with Conjugated Organic Groups. Nano Lett. 2015;15:3657\u201363.","journal-title":"Nano Lett"},{"key":"4459_CR46","doi-asserted-by":"publisher","first-page":"173201","DOI":"10.1088\/0953-8984\/26\/17\/173201","volume":"26","author":"K Dohnalov\u00e1","year":"2014","unstructured":"Dohnalov\u00e1 K, Gregorkiewicz T, K\u016fsov\u00e1 K. Silicon quantum dots: surface matters. J Phys Condens Matter. 2014;26:173201.","journal-title":"J Phys Condens Matter"},{"key":"4459_CR47","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3389\/fchem.2020.00191","volume":"8","author":"S Morozova","year":"2020","unstructured":"Morozova S, et al. Silicon Quantum Dots: Synthesis, Encapsulation, and Application in Light-Emitting Diodes. Front Chem. 2020;8:191.","journal-title":"Front Chem"},{"key":"4459_CR48","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1002\/smll.201102627","volume":"8","author":"J Wang","year":"2012","unstructured":"Wang J, et al. A General Route to Efficient Functionalization of Silicon Quantum Dots for High-Performance Fluorescent Probes. Small. 2012;8:2430\u20135.","journal-title":"Small"},{"issue":"14","key":"4459_CR49","doi-asserted-by":"publisher","first-page":"4853","DOI":"10.1039\/C4CS00486H","volume":"44","author":"M Montalti","year":"2015","unstructured":"Montalti M, Cantelli A, Battistelli G. Nanodiamonds and silicon quantum dots: ultrastable and biocompatible luminescent nanoprobes for long-term bioimaging. Chem Soc Rev. 2015;44(14):4853\u2013921.","journal-title":"Chem Soc Rev"},{"key":"4459_CR50","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.3390\/polym10121312","volume":"10","author":"K Dimos","year":"2018","unstructured":"Dimos K. Tuning carbon dots\u2019 optoelectronic properties with polymers. Polymers. 2018;10:1312.","journal-title":"Polymers"},{"key":"4459_CR51","doi-asserted-by":"publisher","first-page":"035701","DOI":"10.1088\/0957-4484\/19\/03\/035701","volume":"19","author":"DL Nida","year":"2007","unstructured":"Nida DL, et al. Photostability of quantum dots with amphiphilic polymer-based passivation strategies. Nanotechnology. 2007;19:035701.","journal-title":"Nanotechnology"},{"key":"4459_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-55619-7","author":"C Mi","year":"2025","unstructured":"Mi C, et al. Towards non-blinking and photostable perovskite quantum dots. Nat Commun. 2025. https:\/\/doi.org\/10.1038\/s41467-024-55619-7.","journal-title":"Nat Commun"},{"key":"4459_CR53","doi-asserted-by":"crossref","unstructured":"Omogo B, Aldana JF, Heyes CD. Radiative and Nonradiative Lifetime Engineering of Quantum Dots in Multiple Solvents by Surface Atom Stoichiometry and Ligands. J Phys Chem C. 2013:5:117.","DOI":"10.1021\/jp309368q"},{"key":"4459_CR54","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1007\/s10895-022-02968-5","volume":"32","author":"A Yemets","year":"2022","unstructured":"Yemets A, et al. Quantum Dot-Antibody Conjugates for Immunofluorescence Studies of Biomolecules and Subcellular Structures. J Fluoresc. 2022;32:1713\u201323.","journal-title":"J Fluoresc"},{"key":"4459_CR55","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/adhm.201300157","volume":"3","author":"S Chinnathambi","year":"2013","unstructured":"Chinnathambi S, et al. Silicon Quantum Dots for Biological Applications. Adv Healthc Mater. 2013;3:10\u201329.","journal-title":"Adv Healthc Mater"},{"key":"4459_CR56","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1039\/D4NR02990A","volume":"17","author":"S Das","year":"2025","unstructured":"Das S, et al. Boosting quantum efficiency and suppressing self-absorption in CdS quantum dots through interface engineering. Nanoscale. 2025;17:276\u201386.","journal-title":"Nanoscale"},{"key":"4459_CR57","doi-asserted-by":"publisher","DOI":"10.1093\/bulcsj\/uoad002","author":"KI Saitow","year":"2024","unstructured":"Saitow KI. Bright silicon quantum dot synthesis and LED design: insights into size\u2013ligand\u2013property relationships from slow- and fast-band engineering. Bull Chem Soc Jpn. 2024. https:\/\/doi.org\/10.1093\/bulcsj\/uoad002.","journal-title":"Bull Chem Soc Jpn"},{"key":"4459_CR58","doi-asserted-by":"publisher","first-page":"7787","DOI":"10.1021\/acsanm.2c00811","volume":"5","author":"Y Xu","year":"2022","unstructured":"Xu Y, et al. Ligand Effects on Photoluminescence and Electroluminescence of Silicon Quantum Dots for Light-Emitting Diodes. ACS Appl Nano Mater. 2022;5:7787\u201397.","journal-title":"ACS Appl Nano Mater"},{"key":"4459_CR59","doi-asserted-by":"publisher","first-page":"072002","DOI":"10.1088\/1361-6528\/aa542b","volume":"28","author":"I Sychugov","year":"2017","unstructured":"Sychugov I, Valenta J, Linnros J. Probing silicon quantum dots by single-dot techniques. Nanotechnology. 2017;28:072002.","journal-title":"Nanotechnology"},{"key":"4459_CR60","doi-asserted-by":"crossref","unstructured":"Wang X et al. Excited State Properties of Allylamine-Capped Silicon Quantum Dots. J Phys Chem C. 2007:6:111.","DOI":"10.1021\/jp065704v"},{"key":"4459_CR61","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1039\/C3CS60353A","volume":"43","author":"X Cheng","year":"2014","unstructured":"Cheng X, et al. Colloidal silicon quantum dots: from preparation to the modification of self-assembled monolayers (SAMs) for bio-applications. Chem Soc Rev. 2014;43:2680\u2013700.","journal-title":"Chem Soc Rev"},{"key":"4459_CR62","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1021\/acs.chemmater.5b00115","volume":"27","author":"M Dasog","year":"2015","unstructured":"Dasog M, Bader K, Veinot JGC. Influence of halides on the optical properties of silicon quantum dots. Chem Mater. 2015;27:1153\u20136.","journal-title":"Chem Mater"},{"key":"4459_CR63","doi-asserted-by":"publisher","first-page":"7303","DOI":"10.1021\/nn4029234","volume":"7","author":"J Liu","year":"2013","unstructured":"Liu J, et al. Assessing Clinical Prospects of Silicon Quantum Dots: Studies in Mice and Monkeys. ACS Nano. 2013;7:7303\u201310.","journal-title":"ACS Nano"},{"key":"4459_CR64","doi-asserted-by":"publisher","first-page":"22049","DOI":"10.1039\/D0NR03957H","volume":"12","author":"J Sobhanan","year":"2020","unstructured":"Sobhanan J, et al. Toxicity of nanomaterials due to photochemical degradation and the release of heavy metal ions. Nanoscale. 2020;12:22049\u201358.","journal-title":"Nanoscale"},{"key":"4459_CR65","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3109\/07388551.2010.487184","volume":"30","author":"O Obonyo","year":"2010","unstructured":"Obonyo O, et al. Quantum dots synthesis and biological applications as imaging and drug delivery systems. Crit Rev Biotechnol. 2010;30:283\u2013301.","journal-title":"Crit Rev Biotechnol"},{"key":"4459_CR66","doi-asserted-by":"crossref","unstructured":"Sivasankarapillai VS et al. Silicon Quantum Dots, in Promising Theranostic Probes for the Future., CDT. 2019. pp. 1255\u20131263.","DOI":"10.2174\/1389450120666190405152315"},{"issue":"4","key":"4459_CR67","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.physe.2008.11.008","volume":"41","author":"J Derr","year":"2009","unstructured":"Derr J, et al. Quantum confinement regime in silicon nanocrystals. Physica E. 2009;41(4):668\u201370.","journal-title":"Physica E"},{"key":"4459_CR68","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10439-005-9000-9","volume":"34","author":"AM Smith","year":"2006","unstructured":"Smith AM, et al. Engineering Luminescent Quantum Dots for In Vivo Molecular and Cellular Imaging. Ann Biomed Eng. 2006;34:3\u201314.","journal-title":"Ann Biomed Eng"},{"issue":"6","key":"4459_CR69","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1002\/adma.201403848","volume":"27","author":"X Ji","year":"2014","unstructured":"Ji X, et al. Highly fluorescent, photostable, and ultrasmall silicon drug nanocarriers for long-term tumor cell tracking and in-vivo cancer therapy. Adv Mater (Deerfield Beach Fla). 2014;27(6):1029\u201334.","journal-title":"Adv Mater (Deerfield Beach Fla)"},{"key":"4459_CR70","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s40089-018-0262-2","volume":"9","author":"M Ali","year":"2019","unstructured":"Ali M, et al. Synthesis, characterization and cytotoxicity of polyethylene glycol-encapsulated CdTe quantum dots. Int Nano Lett. 2019;9:61\u201371.","journal-title":"Int Nano Lett"},{"issue":"3","key":"4459_CR71","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1039\/D5RA08090H","volume":"16","author":"G Pavel","year":"2026","unstructured":"Pavel G, et al. Green and scalable surface functionalization of silicon quantum dots using water-soluble organic acids for sustainable hybrid materials. RSC Adv. 2026;16(3):2923\u201336.","journal-title":"RSC Adv"},{"key":"4459_CR72","doi-asserted-by":"publisher","first-page":"100172","DOI":"10.1016\/j.nxnano.2025.100172","volume":"7","author":"PS Hanmante","year":"2025","unstructured":"Hanmante PS, et al. Quantum dot nanotechnology: Advancing target drug delivery in Oncology. Next Nanatechnol. 2025;7:100172.","journal-title":"Next Nanatechnol"},{"key":"4459_CR73","doi-asserted-by":"publisher","DOI":"10.34133\/research.0030","author":"J Liu","year":"2023","unstructured":"Liu J, et al. Delivery of biomimetic liposomes via meningeal lymphatic vessels route for targeted therapy of Parkinson\u2019s disease. Research. 2023. https:\/\/doi.org\/10.34133\/research.0030.","journal-title":"Research"},{"key":"4459_CR74","doi-asserted-by":"publisher","first-page":"10138","DOI":"10.1074\/jbc.RA119.011650","volume":"295","author":"J Lautenschl\u00e4ger","year":"2020","unstructured":"Lautenschl\u00e4ger J, et al. Intramitochondrial proteostasis is directly coupled to \u03b1-synuclein and amyloid \u03b21\u201342 pathologies. J Biol Chem. 2020;295:10138\u201352.","journal-title":"J Biol Chem"},{"key":"4459_CR75","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/bph.15684","volume":"179","author":"ME Haque","year":"2021","unstructured":"Haque ME, et al. Targeting \u03b1-synuclein aggregation and its role in mitochondrial dysfunction in Parkinson\u2019s disease. Br J Pharmacol. 2021;179:23\u201345.","journal-title":"Br J Pharmacol"},{"key":"4459_CR76","doi-asserted-by":"publisher","first-page":"29667","DOI":"10.1021\/acsnano.4c08567","volume":"18","author":"Z Luo","year":"2024","unstructured":"Luo Z, et al. Mitochondria-targeted gold biometallization for photoacoustically visualized photothermal cancer therapy. ACS Nano. 2024;18:29667\u201377.","journal-title":"ACS Nano"},{"key":"4459_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09566-3","author":"W Zhang","year":"2019","unstructured":"Zhang W, et al. Mitochondria-specific drug release and reactive oxygen species burst induced by polyprodrug nanoreactors can enhance chemotherapy. Nat Commun. 2019. https:\/\/doi.org\/10.1038\/s41467-019-09566-3.","journal-title":"Nat Commun"},{"key":"4459_CR78","doi-asserted-by":"publisher","first-page":"1900422","DOI":"10.1002\/biot.201900422","volume":"16","author":"D Iannazzo","year":"2020","unstructured":"Iannazzo D, Celesti C, Espro C. Recent Advances on Graphene Quantum Dots as Multifunctional Nanoplatforms for Cancer Treatment. Biotechnol J. 2020;16:1900422.","journal-title":"Biotechnol J"},{"key":"4459_CR79","doi-asserted-by":"publisher","DOI":"10.3390\/ma18184302","author":"N Zahariev","year":"2025","unstructured":"Zahariev N, et al. Functionalized magnetic nanoparticles: can they revolutionize the treatment of neurodegenerative disorders? Materials. 2025. https:\/\/doi.org\/10.3390\/ma18184302.","journal-title":"Materials"},{"key":"4459_CR80","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1016\/j.neurobiolaging.2015.01.014","volume":"36","author":"A Perren","year":"2015","unstructured":"Perren A, et al. FK506 reduces neuroinflammation and dopaminergic neurodegeneration in an \u03b1-synuclein-based rat model for Parkinson\u2019s disease. Neurobiol Aging. 2015;36:1559\u201368.","journal-title":"Neurobiol Aging"},{"key":"4459_CR81","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1196\/annals.1332.016","volume":"1035","author":"A Sidhu","year":"2004","unstructured":"Sidhu A, et al. The Role of \u03b1-Synuclein in Both Neuroprotection and Neurodegeneration. Ann N Y Acad Sci. 2004;1035:250\u201370.","journal-title":"Ann N Y Acad Sci"},{"key":"4459_CR82","doi-asserted-by":"publisher","first-page":"17579","DOI":"10.1074\/jbc.M112.434787","volume":"288","author":"R Shaltiel-Karyo","year":"2013","unstructured":"Shaltiel-Karyo R, et al. Disrupter Is Also a Potent \u03b1-Synuclein (\u03b1-syn) Aggregation Inhibitor: A NOVEL DUAL MECHANISM OF MANNITOL FOR THE TREATMENT OF PARKINSON DISEASE (PD. J Biol Chem. 2013;288:17579\u201388.","journal-title":"J Biol Chem"},{"key":"4459_CR83","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1039\/C9BM01602C","volume":"8","author":"AK Srivastava","year":"2020","unstructured":"Srivastava AK, Choudhury SR, Karmakar S. Melatonin\/polydopamine nanostructures for collective neuroprotection-based Parkinson\u2019s disease therapy. Biomater Sci. 2020;8:1345\u201363.","journal-title":"Biomater Sci"},{"key":"4459_CR84","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2024.1464168","author":"S Ishaq","year":"2025","unstructured":"Ishaq S, et al. Effects of exercise training on nigrostriatal neuroprotection in Parkinson\u2019s disease: a systematic review. Front Neurosci. 2025. https:\/\/doi.org\/10.3389\/fnins.2024.1464168.","journal-title":"Front Neurosci"},{"key":"4459_CR85","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1177\/1073858410385006","volume":"17","author":"A Roy","year":"2011","unstructured":"Roy A, Pahan K. Prospects of statins in Parkinson disease. Neuroscientist. 2011;17:244\u201355.","journal-title":"Neuroscientist"},{"key":"4459_CR86","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3727\/000000007783464731","volume":"16","author":"BS Desai","year":"2007","unstructured":"Desai BS, et al. Blood\u2013Brain Barrier Pathology in Alzheimer\u2019s and Parkinson\u2019s Disease: Implications for Drug Therapy. Cell Transpl. 2007;16:285\u201399.","journal-title":"Cell Transpl"},{"key":"4459_CR87","doi-asserted-by":"publisher","first-page":"8451","DOI":"10.1021\/acs.chemmater.9b02743","volume":"31","author":"Z Li","year":"2019","unstructured":"Li Z, et al. <article-title update=\"added\">Aerosol-phase synthesis and processing of luminescent silicon nanocrystals. Chem Mater. 2019;31:8451\u20138.","journal-title":"Chem Mater"},{"key":"4459_CR88","doi-asserted-by":"publisher","first-page":"7119","DOI":"10.1039\/b909800c","volume":"19","author":"S Yang","year":"2009","unstructured":"Yang S, et al. Ultra-fine \u03b2-SiC quantum dots fabricated by laser ablation in reactive liquid at room temperature and their violet emission. J Mater Chem. 2009;19:7119.","journal-title":"J Mater Chem"},{"key":"4459_CR89","doi-asserted-by":"publisher","first-page":"5728","DOI":"10.1039\/c2cs35117j","volume":"41","author":"M Amelia","year":"2012","unstructured":"Amelia M, et al. Electrochemical properties of CdSe and CdTe quantum dots. Chem Soc Rev. 2012;41:5728.","journal-title":"Chem Soc Rev"},{"key":"4459_CR90","doi-asserted-by":"publisher","first-page":"13484","DOI":"10.1021\/acsami.5b02537","volume":"7","author":"A Miura","year":"2015","unstructured":"Miura A, et al. Crystalline-Amorphous Silicon Nanocomposites with Reduced Thermal Conductivity for Bulk Thermoelectrics. ACS Appl Mater Interfaces. 2015;7:13484\u20139.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4459_CR91","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1021\/acs.accounts.0c00757","volume":"54","author":"K Yi","year":"2021","unstructured":"Yi K, et al. Plasma-Enhanced Chemical Vapor Deposition of Two-Dimensional Materials for Applications. Acc Chem Res. 2021;54:1011\u201322.","journal-title":"Acc Chem Res"},{"key":"4459_CR92","doi-asserted-by":"publisher","first-page":"5209","DOI":"10.1021\/la500945f","volume":"30","author":"X Cheng","year":"2014","unstructured":"Cheng X, et al. Click Chemistry Approach to Functionalizing Silicon Quantum Dots: Applications toward Fluorescent Cellular Imaging. Langmuir. 2014;30:5209\u201316.","journal-title":"Langmuir"},{"key":"4459_CR93","doi-asserted-by":"publisher","first-page":"7038","DOI":"10.1002\/anie.201611526","volume":"56","author":"N Pradhan","year":"2017","unstructured":"Pradhan N, et al. Angew Chem Int Ed. 2017;56:7038\u201354.","journal-title":"Angew Chem Int Ed"},{"key":"4459_CR94","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1039\/C8NR09794A","volume":"11","author":"Y Zhai","year":"2019","unstructured":"Zhai Y, et al. Effective blue-violet photoluminescence through lanthanum and fluorine ions co-doping for CsPbCl3 perovskite quantum dots. Nanoscale. 2019;11:2484\u201391.","journal-title":"Nanoscale"},{"key":"4459_CR95","doi-asserted-by":"publisher","first-page":"014207","DOI":"10.1088\/1468-6996\/15\/1\/014207","volume":"15","author":"B Ghosh","year":"2014","unstructured":"Ghosh B, Shirahata N. Colloidal silicon quantum dots: synthesis and luminescence tuning from the near-UV to the near-IR range. Sci Technol Adv Mater. 2014;15:014207.","journal-title":"Sci Technol Adv Mater"},{"key":"4459_CR96","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1143\/JJAP.46.L833","volume":"46","author":"Y Kurokawa","year":"2007","unstructured":"Kurokawa Y, et al. Photoluminescence from Silicon Quantum Dots in Si Quantum Dots\/Amorphous SiC Superlattice. Jjap. 2007;46:833.","journal-title":"Jjap"},{"key":"4459_CR97","doi-asserted-by":"crossref","unstructured":"Hiller D et al. Boron-Incorporating Silicon Nanocrystals Embedded in SiO2: Absence of Free Carriers vs. B-Induced Defects, Sci Rep, 2017. 7.","DOI":"10.1038\/s41598-017-08814-0"},{"key":"4459_CR98","doi-asserted-by":"publisher","first-page":"15217","DOI":"10.1021\/jacs.5b09602","volume":"137","author":"CY Sun","year":"2015","unstructured":"Sun CY, et al. Tumor Acidity-Sensitive Polymeric Vector for Active Targeted siRNA Delivery. J Am Chem Soc. 2015;137:15217\u201324.","journal-title":"J Am Chem Soc"},{"key":"4459_CR99","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3390\/jcs8010028","volume":"8","author":"S Gaddimath","year":"2024","unstructured":"Gaddimath S, et al. Recent Advances in pH and Redox Responsive Polymer Nanocomposites for Cancer Therapy. J Compos Sci. 2024;8:28.","journal-title":"J Compos Sci"},{"key":"4459_CR100","doi-asserted-by":"publisher","first-page":"244714","DOI":"10.1063\/1.2940735","volume":"128","author":"QS Li","year":"2008","unstructured":"Li QS, et al. Optimal surface functionalization of silicon quantum dots. J Chem Phys. 2008;128:244714.","journal-title":"J Chem Phys"},{"key":"4459_CR101","doi-asserted-by":"publisher","first-page":"2201834","DOI":"10.1002\/adom.202201834","volume":"11","author":"IT Cheong","year":"2022","unstructured":"Cheong IT, et al. Colloidal Silicon Quantum Dot-Based Cavity Light\u2010Emitting Diodes with Narrowed and Tunable Electroluminescence. Adv Opt Mater. 2022;11:2201834.","journal-title":"Adv Opt Mater"},{"key":"4459_CR102","doi-asserted-by":"crossref","unstructured":"Currie AD, Wong JK, Okun MS. A review of temporal interference, nanoparticles, ultrasound, gene therapy, and designer receptors for Parkinson disease. Npj Parkinsons Dis 2024;1:10.","DOI":"10.1038\/s41531-024-00804-0"},{"key":"4459_CR103","doi-asserted-by":"publisher","first-page":"1153568","DOI":"10.1080\/21688370.2016.1153568","volume":"4","author":"AM Grabrucker","year":"2016","unstructured":"Grabrucker AM, et al. Nanoparticle transport across the blood brain barrier. Tissue Barriers. 2016;4:1153568.","journal-title":"Tissue Barriers"},{"key":"4459_CR104","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1002\/mds.29939","volume":"39","author":"S Virameteekul","year":"2024","unstructured":"Virameteekul S, Lees AJ, Bhidayasiri R. Small particles, big potential: polymeric nanoparticles for drug delivery in Parkinson\u2019s disease. Mov Disord. 2024;39:1922\u201337.","journal-title":"Mov Disord"},{"key":"4459_CR105","doi-asserted-by":"publisher","DOI":"10.1021\/jp074160+","author":"JS Biteen","year":"2007","unstructured":"Biteen JS, et al. Plasmon-enhanced photoluminescence of silicon quantum dots: simulation and experiment. J Phys Chem C. 2007. https:\/\/doi.org\/10.1021\/jp074160+.","journal-title":"J. Phys. Chem. C"},{"key":"4459_CR106","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.3390\/nano12132140","volume":"12","author":"A Waris","year":"2022","unstructured":"Waris A, et al. Applications of Various Types of Nanomaterials for the Treatment of Neurological Disorders. Nanomaterials. 2022;12:2140.","journal-title":"Nanomaterials"},{"key":"4459_CR107","doi-asserted-by":"crossref","unstructured":"Hersh AM, Alomari S, Tyler BM. Crossing the Blood-Brain Barrier: Advances in Nanoparticle Technology for Drug Delivery in Neuro-Oncology, IJMS. 2022: p. 23.","DOI":"10.3390\/ijms23084153"},{"key":"4459_CR108","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1007\/s11064-009-0081-y","volume":"34","author":"J Correale","year":"2009","unstructured":"Correale J, Villa A. Cellular elements of the blood-brain barrier. Neurochem Res. 2009;34:2067\u201377.","journal-title":"Neurochem Res"},{"key":"4459_CR109","first-page":"179","volume":"6","author":"SM Stamatovic","year":"2008","unstructured":"Stamatovic SM, Keep RF, Andjelkovic AV. Brain Endothelial Cell-Cell Junctions: How Open Blood Brain Barrier CN. 2008;6:179\u201392.","journal-title":"Brain Endothelial Cell-Cell Junctions: How Open Blood Brain Barrier CN"},{"key":"4459_CR110","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.2174\/1871527315666160915142244","volume":"15","author":"H Bauer","year":"2016","unstructured":"Bauer H. T.J.o.T.B.-B.B.A.M.G.A.T. CNSNDDT. 2016;15:1016\u201329.","journal-title":"CNSNDDT"},{"key":"4459_CR111","doi-asserted-by":"crossref","unstructured":"Linville RM et al. Three-dimensional microenvironment regulates gene expression, function, and tight junction dynamics of iPSC-derived blood\u2013brain barrier microvessels. Fluids Barriers CNS 2022:87:19.","DOI":"10.1186\/s12987-022-00377-1"},{"issue":"3","key":"4459_CR112","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1021\/acsnano.3c10674","volume":"18","author":"S Zha","year":"2024","unstructured":"Zha S, et al. Functionalized nanomaterials capable of crossing the blood\u2013brain barrier. ACS Nano. 2024;18(3):1820\u201345.","journal-title":"ACS Nano"},{"issue":"1","key":"4459_CR113","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/187221112799219125","volume":"6","author":"C Spuch","year":"2012","unstructured":"Spuch C, Saida O, Navarro C. Advances in the treatment of neurodegenerative disorders employing nanoparticles. Recent Pat Drug Deliv Formul. 2012;6(1):2\u201318.","journal-title":"Recent Pat Drug Deliv Formul"},{"issue":"36","key":"4459_CR114","doi-asserted-by":"publisher","first-page":"25271","DOI":"10.1021\/acsnano.4c08516","volume":"18","author":"M Chen","year":"2024","unstructured":"Chen M, et al. Putative Adverse Outcome Pathway for Parkinson\u2019s Disease-like Symptoms Induced by Silicon Quantum Dots based on In Vivo\/Vitro Approaches. ACS Nano. 2024;18(36):25271\u201389.","journal-title":"ACS Nano"},{"issue":"15","key":"4459_CR115","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.1039\/D4NA00028E","volume":"6","author":"Y Hu","year":"2024","unstructured":"Hu Y, et al. Application of quantum dots in brain diseases and their neurotoxic mechanism. Nanoscale Adv. 2024;6(15):3733\u201346.","journal-title":"Nanoscale Adv"},{"key":"4459_CR116","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1007\/s00018-018-2982-x","volume":"76","author":"R Villase\u00f1or","year":"2018","unstructured":"Villase\u00f1or R, et al. Intracellular transport and regulation of transcytosis across the blood\u2013brain barrier. Cell Mol Life Sci. 2018;76:1081\u201392.","journal-title":"Cell Mol Life Sci"},{"key":"4459_CR117","doi-asserted-by":"publisher","first-page":"27030","DOI":"10.1021\/acsami.5c02767","volume":"17","author":"L Zhang","year":"2025","unstructured":"Zhang L, et al. Promoting Drug Delivery to the Brain by Modulating the Transcytosis Process across the Blood-Brain Barrier. ACS Appl Mater Interfaces. 2025;17:27030\u201348.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4459_CR118","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14030672","volume":"14","author":"H Choi","year":"2022","unstructured":"Choi H, et al. Strategies for Targeted Delivery of Exosomes to the Brain. Advantages and challenges. Pharmaceutics. 2022;14:672.","journal-title":"Pharmaceutics"},{"key":"4459_CR119","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3109\/02652048.2012.692491","volume":"30","author":"J Kreuter","year":"2012","unstructured":"Kreuter J. Mechanism of polymeric nanoparticle-based drug transport across the blood-brain barrier (BBB. J Microencapsul. 2012;30:49\u201354.","journal-title":"J Microencapsul"},{"key":"4459_CR120","doi-asserted-by":"publisher","first-page":"698","DOI":"10.2174\/1567201816666190828153017","volume":"16","author":"NI Mansor","year":"2019","unstructured":"Mansor NI, et al. Crossing the Blood-Brain Barrier: A Review on Drug Delivery Strategies for Treatment of the Central Nervous System Diseases. CDD. 2019;16:698\u2013711.","journal-title":"CDD"},{"key":"4459_CR121","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3390\/pharmaceutics17081041","volume":"17","author":"HM Yang","year":"2025","unstructured":"Yang HM. Overcoming the Blood\u2013Brain Barrier: Advanced Strategies in Targeted Drug Delivery for Neurodegenerative Diseases. Pharmaceutics. 2025;17:1041.","journal-title":"Pharmaceutics"},{"key":"4459_CR122","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24323-1","author":"K Kucharz","year":"2021","unstructured":"Kucharz K, et al. Post-capillary venules are the key locus for transcytosis-mediated brain delivery of therapeutic nanoparticles.. Nat Commun. 2021. https:\/\/doi.org\/10.1038\/s41467-021-24323-1.","journal-title":"Nat Commun"},{"key":"4459_CR123","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-025-05417-z","author":"U Kochman","year":"2025","unstructured":"Kochman U, et al. Targeted nanoparticles for drug delivery across the blood-brain barrier in early and late stages of Alzheimer\u2019s disease. A review. Mol Neurobiol. 2025. https:\/\/doi.org\/10.1007\/s12035-025-05417-z.","journal-title":"Mol Neurobiol"},{"key":"4459_CR124","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3390\/antib12030043","volume":"12","author":"T Tashima","year":"2023","unstructured":"Tashima T. Proteolysis-Targeting Chimera (PROTAC) Delivery into the Brain across the Blood-Brain Barrier. Antibodies. 2023;12:43.","journal-title":"Antibodies"},{"key":"4459_CR125","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1166\/jnn.2003.077","volume":"4","author":"J Kreuter","year":"2004","unstructured":"Kreuter J. Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain. J Nanosci Nanotech. 2004;4:484\u20138.","journal-title":"J Nanosci Nanotech"},{"issue":"5","key":"4459_CR126","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3390\/pharmaceutics17050661","volume":"17","author":"M Gomes","year":"2025","unstructured":"Gomes M, et al. Advancing brain targeting: cost-effective surface-modified nanoparticles for faster market entry. Pharmaceutics. 2025;17(5):661.","journal-title":"Pharmaceutics"},{"issue":"1","key":"4459_CR127","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.nano.2016.08.029","volume":"13","author":"N Huang","year":"2017","unstructured":"Huang N, et al. Efficacy of NGR peptide-modified PEGylated quantum dots for crossing the blood\u2013brain barrier and targeted fluorescence imaging of glioma and tumor vasculature. Nanomed Nanotechnol Biol Med. 2017;13(1):83\u201393.","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"4459_CR128","doi-asserted-by":"crossref","unstructured":"Tsukamoto HYR. Quantum dots conjugated with transferrin for brain tumor cell imaging. J Cell Sci Therapy. 2013;4:3.","DOI":"10.4172\/2157-7013.1000150"},{"issue":"7","key":"4459_CR129","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.3390\/molecules30071572","volume":"30","author":"H Omidian","year":"2025","unstructured":"Omidian H, Cubeddu LX, Wilson RL. Peptide-functionalized nanomedicine: advancements in drug delivery, diagnostics, and biomedical applications. Molecules. 2025;30(7):1572.","journal-title":"Molecules"},{"issue":"19","key":"4459_CR130","doi-asserted-by":"publisher","first-page":"3999","DOI":"10.3390\/molecules30193999","volume":"30","author":"P Sokolov","year":"2025","unstructured":"Sokolov P, et al. Methods for Conjugating Antibodies with Quantum Dots. Molecules. 2025;30(19):3999.","journal-title":"Molecules"},{"issue":"1","key":"4459_CR131","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/adhm.201300157","volume":"3","author":"S Chinnathambi","year":"2014","unstructured":"Chinnathambi S, et al. Silicon quantum dots for biological applications. Adv Healthc Mater. 2014;3(1):10\u201329.","journal-title":"Adv Healthc Mater"},{"key":"4459_CR132","doi-asserted-by":"publisher","first-page":"2203070","DOI":"10.1002\/smll.202203070","volume":"18","author":"P Gurnani","year":"2022","unstructured":"Gurnani P, et al. Probing the Effect of Rigidity on the Cellular Uptake of Core-Shell Nanoparticles: Stiffness Effects are Size Dependent. Small. 2022;18:2203070.","journal-title":"Small"},{"key":"4459_CR133","doi-asserted-by":"publisher","first-page":"20410","DOI":"10.1021\/acsami.7b03504","volume":"9","author":"Y Song","year":"2017","unstructured":"Song Y, et al. Vitro Study of Receptor-Mediated Silica Nanoparticles Delivery across Blood-Brain Barrier. ACS Appl Mater Interfaces. 2017;9:20410\u20136.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4459_CR134","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.2174\/1381612826666200212113421","volume":"26","author":"AE Toth","year":"2020","unstructured":"Toth AE, Holst MR, Nielsen MS. Vesicular transport machinery in brain endothelial cells: what we know and what we do not. CPD. 2020;26:1405\u201316.","journal-title":"CPD"},{"key":"4459_CR135","doi-asserted-by":"publisher","first-page":"4137","DOI":"10.1021\/acs.molpharmaceut.5b00597","volume":"12","author":"I Cabez\u00f3n","year":"2015","unstructured":"Cabez\u00f3n I, et al. Trafficking of Gold Nanoparticles Coated with the 8D3 Anti-Transferrin Receptor Antibody at the Mouse Blood-Brain Barrier. Mol Pharm. 2015;12:4137\u201345.","journal-title":"Mol Pharm"},{"key":"4459_CR136","doi-asserted-by":"publisher","DOI":"10.1515\/tnsci-2022-0359","author":"H Cai","year":"2024","unstructured":"Cai H, et al. Lipid-based nanoparticles for drug delivery in Parkinson\u2019s disease.. Transl Neurosci. 2024. https:\/\/doi.org\/10.1515\/tnsci-2022-0359.","journal-title":"Transl Neurosci"},{"key":"4459_CR137","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1586\/ern.10.55","volume":"10","author":"T Yasuda","year":"2010","unstructured":"Yasuda T, Mochizuki H. Use of growth factors for the treatment of Parkinson\u2019s disease. Expert Rev Neurother. 2010;10:915\u201324.","journal-title":"Expert Rev Neurother"},{"key":"4459_CR138","first-page":"261","volume":"14","author":"TJ Collier","year":"1999","unstructured":"Collier TJ, Sortwell CE. Therapeutic potential of nerve growth factors in Parkinson\u2019s disease., Drugs &amp.. Aging. 1999;14:261\u201387.","journal-title":"Aging"},{"issue":"1","key":"4459_CR139","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1186\/1472-6882-14-384","volume":"14","author":"A Garcimart\u00edn","year":"2014","unstructured":"Garcimart\u00edn A, et al. Organic silicon protects human neuroblastoma SH-SY5Y cells against hydrogen peroxide effects. BMC Complement Altern Med. 2014;14(1):384.","journal-title":"BMC Complement Altern Med"},{"key":"4459_CR140","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S267007","author":"J Fonseca-Gomes","year":"2020","unstructured":"Fonseca-Gomes J, et al. In vivo bio-distribution and toxicity evaluation of polymeric and lipid-based nanoparticles: a potential approach for chronic diseases treatment.. Int J Nanomedicine. 2020. https:\/\/doi.org\/10.2147\/IJN.S267007.","journal-title":"Int J Nanomedicine"},{"key":"4459_CR141","doi-asserted-by":"publisher","first-page":"1692707","DOI":"10.3389\/fnins.2025.1692707","volume":"19","author":"S Chen","year":"2025","unstructured":"Chen S, Jiang T. Neuroprotective, eco-friendly iron oxide nanoparticles to alleviate Parkinson\u2019s disease symptoms and improve nursing care. Front NeuroSci. 2025;19:1692707.","journal-title":"Front NeuroSci"},{"key":"4459_CR142","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2498-9","author":"U Anilkumar","year":"2020","unstructured":"Anilkumar U, et al. MCL-1matrix maintains neuronal survival by enhancing mitochondrial integrity and bioenergetic capacity under stress conditions. Cell Death Dis. 2020. https:\/\/doi.org\/10.1038\/s41419-020-2498-9.","journal-title":"Cell Death Dis"},{"key":"4459_CR143","doi-asserted-by":"crossref","unstructured":"Ganjam GK, Bolte K, Matschke LA, Neitemeier S, Dolga AM, H\u00f6llerhage M, H\u00f6glinger GU, Adamczyk A, Decher N, Oertel WH, Culmsee C. Mitochondrial damage by \u03b1-synuclein causes cell death in human dopaminergic neurons. Cell Death Dis. 2019;10:865.","DOI":"10.1038\/s41419-019-2091-2"},{"key":"4459_CR144","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1007\/s12035-024-04357-4","volume":"62","author":"SK Soman","year":"2024","unstructured":"Soman SK, Swain M, Dagda RK. BDNF-TrkB signaling in mitochondria: implications for neurodegenerative diseases. Mol Neurobiol. 2024;62:1756\u201369.","journal-title":"Mol Neurobiol"},{"key":"4459_CR145","doi-asserted-by":"crossref","unstructured":"Conway KA et al. Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct., Science 294. 2001: pp. 1346\u20131349.","DOI":"10.1126\/science.1063522"},{"key":"4459_CR146","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/3311","volume":"4","author":"KA Conway","year":"1998","unstructured":"Conway KA, Harper JD, Lansbury PT. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease. Nat Med. 1998;4:1318\u201320.","journal-title":"Nat Med"},{"key":"4459_CR147","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1096\/fj.03-0770fje","volume":"18","author":"J Li","year":"2004","unstructured":"Li J, et al. Dopamine and L-dopa disaggregate amyloid fibrils: implications for Parkinson\u2019s and Alzheimer\u2019s disease. FASEB J. 2004;18:962\u20134.","journal-title":"FASEB J"},{"key":"4459_CR148","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1007\/s11481-020-09926-7","volume":"15","author":"L Yang","year":"2020","unstructured":"Yang L, et al. Neuroinflammatory Responses and Parkinson\u2019 Disease: Pathogenic Mechanisms and Therapeutic Targets. J Neuroimmune Pharmacol. 2020;15:830\u20137.","journal-title":"J Neuroimmune Pharmacol"},{"key":"4459_CR149","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094956","author":"M Rasheed","year":"2021","unstructured":"Rasheed M, et al. Epigenetic regulation of neuroinflammation in Parkinson\u2019s disease. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22094956.","journal-title":"Int J Mol Sci"},{"key":"4459_CR150","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-025-03165-3","author":"Y Su","year":"2025","unstructured":"Su Y, Su Z. Effects of exercise on neuroinflammation in age-related neurodegenerative disorders. Eur J Med Res. 2025. https:\/\/doi.org\/10.1186\/s40001-025-03165-3.","journal-title":"Eur J Med Res"},{"issue":"4","key":"4459_CR151","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1021\/acsmaterialslett.2c01225","volume":"5","author":"D Yang","year":"2023","unstructured":"Yang D, et al. Recent updates on functionalized silicon quantum-dot-based nanoagents for biomedical applications. ACS Mater Lett. 2023;5(4):985\u20131008.","journal-title":"ACS Mater Lett"},{"issue":"11","key":"4459_CR152","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.2217\/nnm-2023-0326","volume":"19","author":"Q Fang","year":"2024","unstructured":"Fang Q, Tang M. Oxidative stress-induced neurotoxicity of quantum dots and influencing factors. Nanomedicine. 2024;19(11):1013\u201328.","journal-title":"Nanomedicine"},{"issue":"16","key":"4459_CR153","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.1039\/D2MA00984F","volume":"4","author":"D Beri","year":"2023","unstructured":"Beri D. Silicon quantum dots: surface matter, what next? Mater Adv. 2023;4(16):3380\u201398.","journal-title":"Mater Adv"},{"key":"4459_CR154","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/8385961","author":"M Banjara","year":"2017","unstructured":"Banjara M, Ghosh C. Sterile neuroinflammation and strategies for therapeutic intervention. Int J Inflam. 2017. https:\/\/doi.org\/10.1155\/2017\/8385961.","journal-title":"Int J Inflam"},{"key":"4459_CR155","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2024.1347987","author":"A Adamu","year":"2024","unstructured":"Adamu A, et al. The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets. Front Aging Neurosci. 2024. https:\/\/doi.org\/10.3389\/fnagi.2024.1347987.","journal-title":"Front Aging Neurosci"},{"key":"4459_CR156","doi-asserted-by":"publisher","first-page":"600","DOI":"10.3390\/cells14080600","volume":"14","author":"A Volarevic","year":"2025","unstructured":"Volarevic A, et al. Therapeutic Potential of Mesenchymal Stem Cell-Derived Extracellular Vesicles in the Treatment of Parkinson\u2019s Disease. Cells. 2025;14:600.","journal-title":"Cells"},{"key":"4459_CR157","doi-asserted-by":"publisher","first-page":"19450","DOI":"10.1039\/D0NR05003B","volume":"12","author":"M Ghaeidamini","year":"2020","unstructured":"Ghaeidamini M, et al. Graphene oxide sheets and quantum dots inhibit \u03b1-synuclein amyloid formation by different mechanisms. Nanoscale. 2020;12:19450\u201360.","journal-title":"Nanoscale"},{"key":"4459_CR158","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s12276-021-00562-6","volume":"53","author":"C Kim","year":"2021","unstructured":"Kim C, et al. Effects of innate immune receptor stimulation on extracellular \\u03b1-synuclein uptake and degradation by brain resident cells. Exp Mol Med. 2021;53:281\u201390.","journal-title":"Exp Mol Med"},{"key":"4459_CR159","doi-asserted-by":"publisher","first-page":"48416","DOI":"10.1021\/acsami.2c13322","volume":"14","author":"B Li","year":"2022","unstructured":"Li B, et al. Alleviating Neuroinflammation through Photothermal Conjugated Polymer Nanoparticles by Regulating Reactive Oxygen Species and Ca2\u2009+\u2009Signaling. ACS Appl Mater Interfaces. 2022;14:48416\u201325.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4459_CR160","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41582-022-00618-9","volume":"18","author":"JY Lee","year":"2022","unstructured":"Lee JY, et al. Multimodal brain and retinal imaging of dopaminergic degeneration in Parkinson disease. Nat Rev Neurol. 2022;18:203\u201320.","journal-title":"Nat Rev Neurol"},{"key":"4459_CR161","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41582-021-00486-9","volume":"17","author":"D Berg","year":"2021","unstructured":"Berg D, et al. Prodromal Parkinson disease subtypes - key to understanding heterogeneity. Nat Rev Neurol. 2021;17:349\u201361.","journal-title":"Nat Rev Neurol"},{"key":"4459_CR162","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/biot.201500219","volume":"11","author":"A Mukherjee","year":"2015","unstructured":"Mukherjee A, Shim Y, Song JM. Quantum dot as probe for disease diagnosis and monitoring. Biotechnol J. 2015;11:31\u201342.","journal-title":"Biotechnol J"},{"key":"4459_CR163","doi-asserted-by":"publisher","first-page":"7921","DOI":"10.1039\/D0NR00814A","volume":"12","author":"F Romano","year":"2020","unstructured":"Romano F, et al. Water-soluble silicon nanocrystals as NIR luminescent probes for time-gated biomedical imaging. Nanoscale. 2020;12:7921\u20136.","journal-title":"Nanoscale"},{"key":"4459_CR164","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13101226","volume":"13","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, et al. PET imaging with [18F]ROStrace detects oxidative stress and predicts Parkinson\u2019s disease progression in mice. Antioxidants. 2024;13:1226.","journal-title":"Antioxidants"},{"key":"4459_CR165","doi-asserted-by":"publisher","first-page":"38385","DOI":"10.1021\/acsami.9b11263","volume":"11","author":"L Xu","year":"2019","unstructured":"Xu L, et al. Multifunctional Albumin-Based Delivery System Generated by Programmed Assembly for Tumor-Targeted Multimodal Therapy and Imaging. ACS Appl Mater Interfaces. 2019;11:38385\u201394.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4459_CR166","doi-asserted-by":"publisher","first-page":"10870","DOI":"10.1021\/acs.langmuir.6b01867","volume":"32","author":"DA Fernandes","year":"2016","unstructured":"Fernandes DA, et al. Synthesis of Stable Multifunctional Perfluorocarbon Nanoemulsions for Cancer Therapy and Imaging. Langmuir. 2016;32:10870\u201380.","journal-title":"Langmuir"},{"key":"4459_CR167","doi-asserted-by":"publisher","first-page":"505103","DOI":"10.1088\/1361-6528\/aadfbc","volume":"29","author":"DA Fernandes","year":"2018","unstructured":"Fernandes DA, Kolios MC. Intrinsically absorbing photoacoustic and ultrasound contrast agents for cancer therapy and imaging. Nanotechnology. 2018;29:505103.","journal-title":"Nanotechnology"},{"key":"4459_CR168","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-025-03415-w","author":"S Liu","year":"2025","unstructured":"Liu S, et al. Advances in brain-targeted delivery strategies and natural product-mediated enhancement of blood\u2013brain barrier permeability. J Nanobiotechnol. 2025. https:\/\/doi.org\/10.1186\/s12951-025-03415-w.","journal-title":"J Nanobiotechnol"},{"key":"4459_CR169","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3390\/jcm14020386","volume":"14","author":"S Kim","year":"2025","unstructured":"Kim S, Jung UJ, Kim SR. The Crucial Role of the Blood-Brain Barrier in Neurodegenerative Diseases: Mechanisms of Disruption and Therapeutic Implications. JCM. 2025;14:386.","journal-title":"JCM"},{"key":"4459_CR170","doi-asserted-by":"crossref","unstructured":"Janigro D et al. Peripheral Blood and Salivary Biomarkers of Blood-Brain Barrier Permeability and Neuronal Damage. Clinical and Applied Concepts., Front. Neurol, 2021. 11.","DOI":"10.3389\/fneur.2020.577312"},{"key":"4459_CR171","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26062440","author":"AI Beltran-Velasco","year":"2025","unstructured":"Beltran-Velasco AI, Clemente-Su\u00e1rez VJ. Impact of peripheral inflammation on blood-brain barrier dysfunction and its role in neurodegenerative diseases. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms26062440.","journal-title":"Int J Mol Sci"},{"key":"4459_CR172","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1212\/01.wnl.0000310432.92489.90","volume":"70","author":"R Nandhagopal","year":"2008","unstructured":"Nandhagopal R, McKeown MJ, Stoessl AJ. Invited article: functional imaging in Parkinson disease. Neurology. 2008;70:1478\u201388.","journal-title":"Neurology"},{"key":"4459_CR173","doi-asserted-by":"publisher","first-page":"70","DOI":"10.7150\/ntno.21638","volume":"2","author":"S Sonali","year":"2018","unstructured":"Sonali S, et al. Nanotheranostics: Emerging Strategies for Early Diagnosis and Therapy of Brain Cancer. Nanotheranostics. 2018;2:70\u201386.","journal-title":"Nanotheranostics"},{"key":"4459_CR174","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1001\/jamaneurol.2021.1312","volume":"78","author":"T Mitchell","year":"2021","unstructured":"Mitchell T, et al. Emerging Neuroimaging Biomarkers Across Disease Stage in Parkinson Disease. JAMA Neurol. 2021;78:1262.","journal-title":"JAMA Neurol"},{"key":"4459_CR175","doi-asserted-by":"crossref","unstructured":"Hasannejadasl B et al. Quantum Dots Application in Neurodegenerative Diseases, Thrita 9. 2021.","DOI":"10.5812\/thrita.100105"},{"key":"4459_CR176","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1039\/B9NR00178F","volume":"2","author":"YP Ho","year":"2010","unstructured":"Ho YP, Leong KW. Quantum dot-based theranostics. Nanoscale. 2010;2:60\u20138.","journal-title":"Nanoscale"},{"key":"4459_CR177","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14998","author":"X Zhao","year":"2017","unstructured":"Zhao X, et al. Dual-stimuli responsive and reversibly activatable theranostic nanoprobe for precision tumor-targeting and fluorescence-guided photothermal therapy.. Nat Commun. 2017. https:\/\/doi.org\/10.1038\/ncomms14998.","journal-title":"Nat Commun"},{"key":"4459_CR178","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17070912","volume":"17","author":"A N\u00fa\u00f1ez-Salinas","year":"2025","unstructured":"N\u00fa\u00f1ez-Salinas A, et al. Nanoradiopharmaceuticals: design principles. Radiolabeling strategies, and biomedicine applications. Pharmaceutics. 2025;17:912.","journal-title":"Pharmaceutics"},{"key":"4459_CR179","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000003745","author":"D Su","year":"2025","unstructured":"Su D, Zheng Y, Feng T. Biomarkers and neuroimaging markers in Parkinson\u2019s disease.. Chin Med J. 2025. https:\/\/doi.org\/10.1097\/CM9.0000000000003745.","journal-title":"Chin Med J"},{"key":"4459_CR180","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3390\/jcm9010089","volume":"9","author":"E Forte","year":"2019","unstructured":"Forte E, et al. Radiolabeled PET\/MRI Nanoparticles for Tumor Imaging. JCM. 2019;9:89.","journal-title":"JCM"},{"key":"4459_CR181","doi-asserted-by":"publisher","first-page":"2100378","DOI":"10.1002\/smll.202100378","volume":"17","author":"L Xia","year":"2021","unstructured":"Xia L, et al. A Highly Specific Multiple Enhancement Theranostic Nanoprobe for PET\/MRI\/PAI Image-Guided Radioisotope Combined Photothermal Therapy in Prostate Cancer. Small. 2021;17:2100378.","journal-title":"Small"},{"key":"4459_CR182","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1002\/glia.22496","volume":"61","author":"M Lazzarini","year":"2013","unstructured":"Lazzarini M, et al. Doxycycline restrains glia and confers neuroprotection in a 6-OHDA Parkinson model. Glia. 2013;61:1084\u2013100.","journal-title":"Glia"},{"key":"4459_CR183","doi-asserted-by":"crossref","unstructured":"Saramowicz K et al. Alpha-Synuclein Contribution to Neuronal and Glial Damage in Parkinson\u2019s Disease., IJMS. 2023: p. 25.","DOI":"10.3390\/ijms25010360"},{"key":"4459_CR184","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1038\/s41593-019-0486-0","volume":"22","author":"AU Joshi","year":"2019","unstructured":"Joshi AU, et al. Fragmented mitochondria released from microglia trigger A1 astrocytic response and propagate inflammatory neurodegeneration. Nat Neurosci. 2019;22:1635\u201348.","journal-title":"Nat Neurosci"},{"key":"4459_CR185","doi-asserted-by":"crossref","unstructured":"Fu Y et al. in Inhibits Microglial Activation and Improves Neuronal Survival against Neuroinflammation in BV2 Microglial Cells with Lipopolysaccharide Stimulation., Evidence-Based Complementary and Alternative Medicine 2017. 2017. pp. 1\u201312.","DOI":"10.1155\/2017\/4730878"},{"key":"4459_CR186","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1111\/j.1471-4159.2008.05675.x","volume":"107","author":"LT Zheng","year":"2008","unstructured":"Zheng LT, et al. The antipsychotic spiperone attenuates inflammatory response in cultured microglia via the reduction of proinflammatory cytokine expression and nitric oxide production. J Neurochem. 2008;107:1225\u201335.","journal-title":"J Neurochem"},{"key":"4459_CR187","doi-asserted-by":"publisher","DOI":"10.1186\/2051-5960-1-6","author":"H Dimant","year":"2013","unstructured":"Dimant H, et al. Direct detection of alpha synuclein oligomers in vivo.. Acta Neuropathol Commun. 2013. https:\/\/doi.org\/10.1186\/2051-5960-1-6.","journal-title":"Acta Neuropathol Commun"},{"key":"4459_CR188","doi-asserted-by":"crossref","unstructured":"Chia SJ, Tan EK, Chao YX. Hist Perspective: Models Parkinson\u2019s Disease IJMS 2020;21(7):21.","DOI":"10.3390\/ijms21072464"},{"key":"4459_CR189","doi-asserted-by":"crossref","unstructured":"Lane E, Dunnett S. Animal models of Parkinson\u2019s disease and L-dopa induced dyskinesia: how close are we to the clinic? Psychopharmacology 199. 2007: pp. 303\u2013312.","DOI":"10.1007\/s00213-007-0931-8"},{"key":"4459_CR190","doi-asserted-by":"publisher","first-page":"175909141877743","DOI":"10.1177\/1759091418777438","volume":"10","author":"XS Zeng","year":"2018","unstructured":"Zeng XS, Geng WS, Jia JJ. Neurotoxin-Induced Animal Models of Parkinson Disease: Pathogenic Mechanism and Assessment. ASN Neuro. 2018;10:175909141877743.","journal-title":"ASN Neuro"},{"key":"4459_CR191","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/BF01291788","volume":"103","author":"M Gerlach","year":"1996","unstructured":"Gerlach M, Riederer P. Animal models of Parkinson\u2019s disease: an empirical comparison with the phenomenology of the disease in man. J Neural Transm. 1996;103:987\u20131041.","journal-title":"J Neural Transm"},{"key":"4459_CR192","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.2174\/1871527315666160920160512","volume":"15","author":"H Javed","year":"2016","unstructured":"Javed H, Kamal M, Ojha S. An overview on the role of \u03b1 -Synuclein in experimental models of Parkinson\u2019s disease from pathogenesis to therapeutics. CNSNDDT. 2016;15:1240\u201352.","journal-title":"CNSNDDT"},{"key":"4459_CR193","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3390\/nano14050457","volume":"14","author":"RE Cristian","year":"2024","unstructured":"Cristian RE, et al. Vivo Assessment of Hepatic and Kidney Toxicity Induced by Silicon Quantum Dots in Mice. Nanomaterials. 2024;14:457.","journal-title":"Nanomaterials"},{"key":"4459_CR194","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.1039\/D4TB02428A","volume":"13","author":"A Mansour","year":"2025","unstructured":"Mansour A, Eldin MH, El-Sherbiny IM. Metallic nanomaterials in Parkinson\u2019s disease: a transformative approach for early detection and targeted therapy. J Mater Chem B. 2025;13:3806\u201330.","journal-title":"J Mater Chem B"},{"key":"4459_CR195","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23094508","author":"E Guatteo","year":"2022","unstructured":"Guatteo E, et al. Pathophysiological features of nigral dopaminergic neurons in animal models of Parkinson\u2019s disease. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23094508.","journal-title":"Int J Mol Sci"},{"key":"4459_CR196","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/smll.200800003","volume":"5","author":"ML Schipper","year":"2009","unstructured":"Schipper ML, et al. Particle Size, Surface Coating, and PEGylation Influence the Biodistribution of Quantum Dots in Living Mice. Small. 2009;5:126\u201334.","journal-title":"Small"},{"key":"4459_CR197","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1021\/mp800051m","volume":"5","author":"F Alexis","year":"2008","unstructured":"Alexis F, et al. Farokhzad, Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles. Mol Pharm. 2008;5:505\u201315.","journal-title":"Mol Pharm"},{"key":"4459_CR198","doi-asserted-by":"crossref","unstructured":"Zhao Y, Haney MJ. Active Targeted Macrophage-mediated Delivery of Catalase to Affected Brain Regions in Models of Parkinson?s Disease. J Nanomed Nanotechnol, 2011;S4:003.","DOI":"10.4172\/2157-7439.S4-003"},{"key":"4459_CR199","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/nrd.2018.136","volume":"17","author":"D Charvin","year":"2018","unstructured":"Charvin D, et al. Therapeutic strategies for Parkinson disease: beyond dopaminergic drugs. Nat Rev Drug Discov. 2018;17:804\u201322.","journal-title":"Nat Rev Drug Discov"},{"key":"4459_CR200","doi-asserted-by":"publisher","first-page":"9062","DOI":"10.1021\/acs.jmedchem.6b00976","volume":"59","author":"YD Wang","year":"2016","unstructured":"Wang YD, et al. A Novel Parkinson\u2019s Disease Drug Candidate with Potent Anti-neuroinflammatory Effects through the Src Signaling Pathway. J Med Chem. 2016;59:9062\u201379.","journal-title":"J Med Chem"},{"key":"4459_CR201","doi-asserted-by":"publisher","first-page":"6169","DOI":"10.1021\/acs.jmedchem.6b00297","volume":"59","author":"GL Douaron","year":"2016","unstructured":"Douaron GL, et al. New 6-Aminoquinoxaline Derivatives with Neuroprotective Effect on Dopaminergic Neurons in Cellular and Animal Parkinson Disease Models. J Med Chem. 2016;59:6169\u201386.","journal-title":"J Med Chem"},{"key":"4459_CR202","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-024-00906-w","author":"J Yu","year":"2024","unstructured":"Yu J, et al. State of the art of silica nanoparticles: an overview on biodistribution and preclinical toxicity studies. AAPS J. 2024. https:\/\/doi.org\/10.1208\/s12248-024-00906-w.","journal-title":"AAPS J"},{"key":"4459_CR203","doi-asserted-by":"crossref","unstructured":"Chen M et al. The discovery of regional neurotoxicity-associated metabolic alterations induced by carbon quantum dots in brain of mice using a spatial metabolomics analysis. Part Fibre Toxicol 2024;21(1):19.","DOI":"10.1186\/s12989-024-00580-y"},{"key":"4459_CR204","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/jat.3229","volume":"36","author":"T Wu","year":"2015","unstructured":"Wu T, et al. Research advances on potential neurotoxicity of quantum dots. J Appl Toxicol. 2015;36:345\u201351.","journal-title":"J Appl Toxicol"},{"key":"4459_CR205","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3390\/toxics13070519","volume":"13","author":"WA Tamagno","year":"2025","unstructured":"Tamagno WA, Freeman JL. Glutamate-mediated neural alterations in lead exposure: mechanisms, pathways, and phenotypes. Toxics. 2025;13:519.","journal-title":"Toxics"},{"key":"4459_CR206","first-page":"1","volume":"2013","author":"B Wang","year":"2013","unstructured":"Wang B, Du Y. Cadmium and its neurotoxic effects. Oxid Med Cell Longev. 2013;2013:1\u201312.","journal-title":"Oxid Med Cell Longev"},{"key":"4459_CR207","doi-asserted-by":"publisher","first-page":"422","DOI":"10.17305\/bjbms.2020.5181","volume":"21","author":"M Mustapha","year":"2021","unstructured":"Mustapha M, Taib C. MPTP-induced mouse model of Parkinson\u2019s disease: a promising direction of therapeutic strategies. Biomol Biomed. 2021;21:422\u201333.","journal-title":"Biomol Biomed"},{"key":"4459_CR208","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s00702-024-02846-3","volume":"132","author":"KA Jellinger","year":"2024","unstructured":"Jellinger KA. Behavioral disorders in Parkinson disease: current view. J Neural Transm. 2024;132:169\u2013201.","journal-title":"J Neural Transm"},{"key":"4459_CR209","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1011947","author":"E Pajarillo","year":"2022","unstructured":"Pajarillo E, et al. Mechanisms of manganese-induced neurotoxicity and the pursuit of neurotherapeutic strategies. Front Pharmacol. 2022. https:\/\/doi.org\/10.3389\/fphar.2022.1011947.","journal-title":"Front Pharmacol"},{"key":"4459_CR210","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1039\/c2nr11763k","volume":"4","author":"R Intartaglia","year":"2012","unstructured":"Intartaglia R, et al. Bioconjugated silicon quantum dots from one-step green synthesis. Nanoscale. 2012;4:1271.","journal-title":"Nanoscale"},{"key":"4459_CR211","doi-asserted-by":"publisher","first-page":"123102","DOI":"10.1063\/1.2187434","volume":"88","author":"TW Kim","year":"2006","unstructured":"Kim TW, et al. Quantum confinement effect in crystalline silicon quantum dots in silicon nitride grown using SiH4 and NH3. Appl Phys Lett. 2006;88:123102.","journal-title":"Appl Phys Lett"},{"key":"4459_CR212","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1039\/c1nr10458f","volume":"3","author":"A Shiohara","year":"2011","unstructured":"Shiohara A, et al. Sized controlled synthesis, purification, and cell studies with silicon quantum dots. Nanoscale. 2011;3:3364.","journal-title":"Nanoscale"},{"key":"4459_CR213","doi-asserted-by":"publisher","first-page":"171601","DOI":"10.1063\/1.4761945","volume":"101","author":"WQ Huang","year":"2012","unstructured":"Huang WQ, et al. Electronic states and curved surface effect of silicon quantum dots. Appl Phys Lett. 2012;101:171601.","journal-title":"Appl Phys Lett"},{"key":"4459_CR214","doi-asserted-by":"publisher","first-page":"5532","DOI":"10.1021\/nl302412f","volume":"12","author":"MA Malfatti","year":"2012","unstructured":"Malfatti MA, et al. Determining the pharmacokinetics and long-term biodistribution of SiO2 nanoparticles in vivo using accelerator mass spectrometry. Nano Lett. 2012;12:5532\u20138.","journal-title":"Nano Lett"},{"key":"4459_CR215","first-page":"747","volume":"4","author":"R Bjorkland","year":"2017","unstructured":"Bjorkland R, Tobias D, Petersen EJ. Increasing Evid indicates low bioaccumulation carbon nanotubes Environ Sci : Nano. 2017;4:747\u201366.","journal-title":"Increasing Evid indicates low bioaccumulation carbon nanotubes Environ Sci : Nano"},{"key":"4459_CR216","doi-asserted-by":"publisher","first-page":"5426","DOI":"10.1039\/D4RA07798A","volume":"15","author":"M Alaei","year":"2025","unstructured":"Alaei M, et al. Metal nanoparticles in neuroinflammation: impact on microglial dynamics and CNS function. RSC Adv. 2025;15:5426\u201351.","journal-title":"RSC Adv"},{"key":"4459_CR217","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1007\/s12015-022-10501-1","volume":"19","author":"W Ni","year":"2023","unstructured":"Ni W, et al. Immunomodulatory and Anti-inflammatory effect of Neural Stem\/Progenitor Cells in the Central Nervous System. Stem Cell Rev Rep. 2023;19:866\u201385.","journal-title":"Stem Cell Rev Rep"},{"key":"4459_CR218","doi-asserted-by":"publisher","first-page":"030902","DOI":"10.1063\/5.0013178","volume":"4","author":"N Zhao","year":"2020","unstructured":"Zhao N, et al. Microglia-targeting nanotherapeutics for neurodegenerative diseases. APL Bioeng. 2020;4:030902.","journal-title":"APL Bioeng"},{"key":"4459_CR219","doi-asserted-by":"publisher","first-page":"5401","DOI":"10.2174\/1381612821666150917093232","volume":"21","author":"J Wang","year":"2015","unstructured":"Wang J, et al. Opportunities and Challenges of Fluorescent Carbon Dots in Translational Optical Imaging. CPD. 2015;21:5401\u201316.","journal-title":"CPD"},{"key":"4459_CR220","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1021\/acs.nanolett.6b04201","volume":"17","author":"RH Gilmore","year":"2017","unstructured":"Gilmore RH, et al. Charge Carrier Hopping Dynamics in Homogeneously Broadened PbS Quantum Dot Solids. Nano Lett. 2017;17:893\u2013901.","journal-title":"Nano Lett"},{"key":"4459_CR221","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00401-020-02181-3","volume":"140","author":"S Bandres-Ciga","year":"2020","unstructured":"Bandres-Ciga S, et al. Large-scale pathway specific polygenic risk and transcriptomic community network analysis identifies novel functional pathways in Parkinson disease. Acta Neuropathol. 2020;140:341\u201358.","journal-title":"Acta Neuropathol"},{"key":"4459_CR222","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1002\/mds.26642","volume":"31","author":"AJ Espay","year":"2016","unstructured":"Espay AJ, et al. Technology in Parkinson\u2019s disease: challenges and opportunities. Mov Disord. 2016;31:1272\u201382.","journal-title":"Mov Disord"},{"key":"4459_CR223","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1146\/annurev-pharmtox-022124-033653","volume":"65","author":"E Menozzi","year":"2025","unstructured":"Menozzi E, Schapira AHV. Prospects for disease slowing in Parkinson disease. Annu Rev Pharmacol Toxicol. 2025;65:237\u201358.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"4459_CR224","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1002\/mds.27671","volume":"34","author":"AJ Espay","year":"2019","unstructured":"Espay AJ, et al. A roadmap for implementation of patient-centered digital outcome measures in Parkinson\u2019s disease obtained using mobile health technologies. Mov Disord. 2019;34:657\u201363.","journal-title":"Mov Disord"},{"key":"4459_CR225","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/s41578-023-00581-x","volume":"8","author":"PJ Gawne","year":"2023","unstructured":"Gawne PJ, et al. New opportunities and old challenges in the clinical translation of nanotheranostics. Nat Rev Mater. 2023;8:783\u201398.","journal-title":"Nat Rev Mater"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04459-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04459-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04459-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T07:02:00Z","timestamp":1787209320000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04459-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":225,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4459"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04459-2","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"2 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"787"}}